(19)
(11) EP 3 691 674 A1

(12)

(43) Date of publication:
12.08.2020 Bulletin 2020/33

(21) Application number: 18778510.0

(22) Date of filing: 02.10.2018
(51) International Patent Classification (IPC): 
A61K 38/44(2006.01)
 A61P 9/04(2006.01)
(86) International application number:
PCT/EP2018/076735
(87) International publication number:
WO 2019/068682 (11.04.2019 Gazette 2019/15)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
KH MA MD TN

(30) Priority: 03.10.2017 EP 17306319

(71) Applicants:
  • INSERM (Institut National de la Santé et de la Recherche Médicale)
    75013 Paris (FR)
  • Université de Rouen Normandie
    76821 Mont-Saint-Aignan (FR)
  • Universita' Della Calabria
    87036 Arcavacata di Rende (CS) (IT)

(72) Inventors:
  • ANOUAR, Youssef
    76130 Mont-Saint-Aignan (FR)
  • ANGELONE, Tommaso
    87036 Arcavacata di Rende (CS) (IT)
  • BOUKHZAR, Loubna
    76130 Mont-Saint-Aignan (FR)
  • ROCCA, Carmine
    87036 Arcavacata di Rende (CS) (IT)

(74) Representative: Perronace, Andrea et al
Jacobacci & Partners S.p.A. Via Tomacelli, 146
00186 Roma
00186 Roma (IT)

   


(54) METHODS AND PHARMACEUTICAL COMPOSITIONS FOR PROVIDING CARDIOPROTECTION IN SUBJECTS WHO EXPERIENCED A MYOCARDIAL INFARCTION